IQ HUB

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Overview

KEYTRUDA mode of action

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

Adverse Event management and identification

A guide to KEYTRUDA® (pembrolizumab) and how to manage immune-mediated adverse events

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

Patient assets

Click here to download KEYTRUDA Metastatic Monotherapy Patient Diary

KEYTRUDA® (pembrolizumab) monotherapy patient diary

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

KEYTRUDA® (pembrolizumab) in combination with chemotherapy patient diary

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

Other resources

KEYTRUDA in cervical cancer resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in endometrial cancer resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in first-line metastatic head and neck squamous cell carcinoma (HNSCC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in locally advanced unresectable or metastatic oesophago-gastric cancer resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in metastatic colorectal cancer (CRC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in metastatic non-small cell lung cancer (NSCLC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in adjuvant renal cell carcinoma (RCC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in advanced Renal Cell Carcinoma (aRCC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in melanoma resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA in triple-negative breast cancer (TNBC) resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website